已收盘 02-06 16:00:00 美东时间
+8.400
+2.05%
今日重点评级关注:康托·菲茨杰拉德:维持Wave Life Sciences Ltd."超配"评级,目标价从34美元升至41美元;Piper Sandler:维持Replimune Group"超配"评级,目标价从13美元升至14美元
02-06 16:52
绩优股飙升!精密计时龙头SiTime涨近18%,Q4财报超预期同时公布重大收购;麦克森药物批发涨超16%,26Q3业绩超预期;恩赛因绩后涨近14%>>
02-06 15:30
U.S. stocks were lower, with the Dow Jones index falling more than 350 points o...
02-06 01:07
SiTime (SITM) shares surged more than 16% in early trading on Thursday after several Wall Street firms praised the company's stronger-than-expected results and its deal to acquire a Renesas unit. Barc...
02-05 22:58
华盛资讯2月5日讯,SiTime Corporation公布2025财年Q4业绩,公司Q4营收1.13亿美元,同比增长66.3%,归母净利润0.09亿美元,扭亏为盈。
02-05 22:07
Needham analyst N. Quinn Bolton maintains SiTime (NASDAQ:SITM) with a Buy and raises the price target from $400 to $450.
02-05 20:18
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据SiTime业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **2025财年全年业绩:** - 营收:3.267亿美元,同比增长61% - Non-GAAP每股收益:3.20美元,较2024年0.93美元增长超过3倍 - 毛利率:59.3% - Non-GAAP营业利润:5,860万美元,同比增长5,800万美元,占营收18% - 经营现金流:8,720万美元,较2024年2,320万美元大幅改善 **2025年第四季度业绩:** - 营收:1.133亿美元,同比增长66%,环比增长36%,首次突破1亿美元 - Non-GAAP每股收
02-05 12:30
SiTime (NASDAQ:SITM) reported quarterly earnings of $1.53 per share which beat the analyst consensus estimate of $1.21 by 26.66 percent. This is a 218.75 percent increase over earnings of $0.48 per share from the same
02-05 05:14